ArticleJournal of neuromuscular diseases2023

Pamrevlumab, a Fully Human Monoclonal Antibody Targeting Connective Tissue Growth Factor, for Non-Ambulatory Patients with Duchenne Muscular Dystrophy.

Anne M Connolly et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.